|Active Pharmaceutical Ingredients Development|
|1.||The development of Cephalospornic antibiotics and intermediaries; especially, Cephalexin has been certified by the U.S.FDA in 1994.|
|2.||R&D leading high-end drug stocks focusing on treatment arthritis, osteoporosis, BPH, and cardiovascular diseases.|
|3.||Developing ingredients and intermediaries by ferment method|
|Pharmaceutical Finished & Biotech Related Products Development:|
|1.||Chinese herbal Product R&D|
Researching and developing methods including extraction, purification, and formula development help bring natural substances and Chinese herbal into the domain of health food and drugs
|2.||Controlled release drugs|
A controlled release drugs have been developed to excel the quality of drug dispensing.
|3.||Sterile formulation development|
Backed by professional know-how and the unique processing equipment are adopted for leading sterile formulas research, produced by the automated PE Blowing-filling-sealing.
|4.||Dialysis treatment drugs|
Developing most comprehensive dialysis drugs of in ensemble for the local market.
|5.||Contact lens solution and ophthalmic drugs|
The unit dose package formula to improve the usage quality and easy to use.
|6.||Oral hygiene products|
The supplying of school children to prevent dental caries used in mouthwash and related products
|7.||BE drug development|
78 products have till 2005 been BE tested and certified.
|Technical collaboration pact:|
|A technical collaboration pact working with the U.S. pharmaceutical development firm, Medinox, has yield a series of nitro oxide based and internal disease inhibiting drugs, designed to combat septic shocks, adult respiratory arrest, diabetes, and so forth.|